Pages
Products
CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER

Cytology

Utility of the Ba/F3 Cell System for Exploring On‐target Mechanisms of Resistance to Targeted Therapies for Lung Cancer

The development and approvals of targeted drugs have improved treatment outcomes of patients with NSCLC harboring driver mutations. This progress in oncology is encouraging; however, mechanistic analyses of acquired resistance to these targeted drugs is necessary to further improve patient outcomes.

* For research use only. Not intended for any clinical use.
Quick Inquiry